Grunnet, Lars G
Novo Nordisk (Denmark)
3 papers on CoChat
Most cited papers
- Verified
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus
Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine
Histone Deacetylase Inhibitors ResearchSirtuins and Resveratrol in Medicine
Cited by 261
- Verified
Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation
Liu, Q., Chiu, A., Wang, L.-H., An, D., Zhong, M., Smink, A. M., de Haan, B. J., de Vos, P., Keane, K., Vegge, A., et al. (2019) · Nature Communications
Tissue Engineering and Regenerative MedicinePancreatic function and diabetes
Cited by 202
- Verified
Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes
An, D., Chiu, A., Flanders, J. A., Song, W., Shou, D., Lu, Y.-C., Grunnet, L. G., Winkel, L., Ingvorsen, C., Christophersen, N. S., et al. (2018) · Proceedings of the National Academy of Sciences
Pancreatic function and diabetesTissue Engineering and Regenerative Medicine
Cited by 200
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free